intravitreal, VEGF Therapy, macula

CLASSIFIEDS

Find the job that’s right for you. PhysiciansJobsPlus allows you to post your resume, receive relevant ophthalmology open position alerts via email and apply for positions online.

Cover Image Not Available

July 2010

Features

Diabetic Retinopathy: The Masqueraders
By:  Irene A. Barbazetto, M.D.
Clinical hallmarks of DR can be associated with a variety of diseases

How Baseline Assessment of AMD Lesion Type Influences Clinical Decisions and Outcomes
By:  Usha Chakravarthy, MD, FRCS, FRCOphth, PhD; Stuart McGimpsey, MD, FRCOphth; Clara McAvoy, MD, FRCOphth
Careful diagnosis and phenotyping of neovascular AMD patients is still required in the anti-VEGF era

Great Debates in RVO Therapy
By:  Frank Celia, Contributing Editor
An anti-VEGF and steroid gain FDA sanction, but many clinical questions remain

A Brave New World
By:  Pravin U. Dugel, MD; Ram Palanki, PharmD; Kuo Bianchini Tong, MS
The retina subspecialty is in the vanguard of changes to clinical practice and reimbursement

Visualization Agents for Vitreoretinal Surgery
By:  Andrew E. Mathis, PhD, Medical Editor
Intraoperative dyes can be a useful adjunct, but what are the pros and cons? Surgeons share their insights

Case Report
By:  Kevin K. Suk, MD; Audina M. Berrocal, MD; Timothy G. Murray, MD, MBA; Ditte Hess, CRA
Intravitreal Bevacizumab in a Silicone-filled Eye

Microperimetry and Pituitary Adenoma
By:  Federico M. Rathschuler, MD
Benign tumors can present as retinal symptoms

Departments

Upfront: From the Editor-in-Chief
By:  Jason S. Slakter, M.D.
Shortcuts

Subspecialty News
Small study jumps the gun on CATT; Data on PDT/Lucentis combinations; Radiation as a supplement to Anti-VEGF; and more

Controversies in Care
By:  Michael Colucciello, MD
Avastin vs Lucentis for the treatment of neovascular AMD

Journal Club
By:  Andrew E. Mathis, PhD, Medical Editor
Studies to stimulate discussion and debate

Coding Q & A
By:  Riva Lee Asbell
Audit-causing issues in the retina practice

Focus On
By:  Jack Persico, Executive Editor
The InVitria injection assistant




AWS-#2